Daniel L. Alkon - Jul 13, 2021 Form 4/A - Amendment Insider Report for Synaptogenix, Inc. (SNPX)

Role
President and CSO, Director
Signature
/s/ Robert Weinstein, Attorney-in-fact
Stock symbol
SNPX
Transactions as of
Jul 13, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
12/1/2022, 06:53 PM
Date Of Original Report
Jul 15, 2021
Previous filing
Jun 16, 2021
Next filing
Dec 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNPX Common Stock, par value $0.0001 per share Award $0 +43.8K +380.96% $0.00 55.2K Jul 13, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This filing amends the Form 4, filed on July 15, 2021 by Mr. Alkon to reflect the lower number of options allowed to be granted pursuant to the per-participant grant limit contained in the Issuer's 2020 Equity Incentive Plan, as amended.